We hypothesized that microglia-specific knock-out of miR-155 in the APP/PS1 mouse model of AD would lead to upregulation of anti-inflammatory profiles of microglia, reduced amyloid pathology, and therefore increased survival of the mouse model. This evidence concerns the gene APP and Alzheimer disease.